Table 1 De novo variants of 229 NDD genes identified from CHD individuals of DDD Plus Study and PCGC cohorts.

From: De novo damaging variants associated with congenital heart diseases contribute to the connectome

Variant Category

DDD Plus Study-Sifrim 2016 (N = 1039)

PCGC-Jin 2017 (N = 2645)

Combined CHD (N = 3684)

Controls (N = 1789)

Allele Count

OR

95% CI

p-value

Allele Count

OR

95% CI

p-value

Allele Count

OR

95% CI

p-value

Allele Count

Total

94

2.80

2.00, 3.93

1.50E-09

163

1.79

1.32, 2.44

1.52E-04

257

2.07

1.54, 2.77

2.96E-07

57

PT

44

10.48

3.76, 18.31

1.33E-12

62

5.51

2.52, 12.07

2.60E-07

106

6.87

3.19, 14.78

1.72E-10

7

Missense

44

1.90

1.02, 2.38

0.0054

75

1.21

0.82, 1.80

0.38

119

1.40

0.97, 2.02

0.079

38

D-mis

23

3.13

1.19, 4.72

0.0013

33

1.69

0.87, 3.28

0.12

56

2.08

1.11, 3.90

0.017

12

PT or D-mis

67

5.97

2.79, 7.67

4.81E-14

95

3.13

1.90, 5.14

7.10E-07

162

3.89

2.41, 6.28

7.80E-11

19

Non D-mis

21

1.31

0.68, 2.01

0.37

42

0.99

0.60, 1.62

1.0

63

1.08

0.68, 1.70

0.82

26

SYN

6

0.80

0.25, 1.61

0.81

26

1.33

0.67, 2.64

0.50

32

1.18

0.61, 2.30

0.74

12